The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is 74.94 USD. With the latest stock price at 46.97 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is 59.5%.
Based on the latest price of 46.97 USD and our DCF valuation, Rigel Pharmaceuticals Inc (RIGL) is a buy. buying RIGL stocks now will result in a potential gain of 59.5%.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 10.8% | 9.2% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 61.83 - 96.19 | 74.94 |
| Upside | 31.6% - 104.8% | 59.5% |